pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Gene Therapy (AAV) · news · pharmadog
← back to Gene Therapy (AAV)
News · Gene Therapy (AAV)
221
stories
Jun 18, 26
New hope in treating Huntington’s disease and a report card on RFK Jr.’s promises
stat
Jun 18, 26
Pfizer CFO to step down; Denali sells a regulatory fast-pass
biopharma dive
Jun 17, 26
UniQure to file gene therapy for approval, reflecting major shifts at FDA
biopharma dive
Jun 17, 26
Update: Spot Bio launches with $40M to study non-viral gene therapy for muscular dystrophy
endpoints
Jun 16, 26
Neumora depression drug fails; EnGene to cut 50% of staff
biopharma dive
Jun 11, 26
Sensorion, citing Regeneron competition, shifts focus to a different hearing loss therapy
biopharma dive
Jun 11, 26
Novartis RNA drug acquired in $12B Avidity deal notches a trial win
biopharma dive
Jun 10, 26
SonoThera raises $125M for non-viral gene therapy approach
endpoints
Jun 10, 26
Opinion: Even in abortion-protecting states, teens face unnecessary barriers to care
stat
Jun 10, 26
Opinion: ‘They all think I’m insane’: What it’s like to start medical residency at 72
stat
Jun 9, 26
STAT+: Trump’s health care affordability czar takes aim at hospitals
stat
Jun 9, 26
Grace Science says FDA bottleneck jeopardizes rare disease therapy
endpoints
Jun 9, 26
Gilead and Merck’s latest trial success and flop
stat
Jun 9, 26
Opinion: Ending animal testing could set back xenotransplantation just as the field is poised for a breakthrough
stat
Jun 9, 26
Opinion: Why STAT is sticking with ‘health care’ as two words
stat
Jun 8, 26
STAT+: Novo underwhelmed by drug it once fought Pfizer for
stat
Jun 8, 26
STAT+: J&J spends $1 billion to enter KRAS race for cancer treatments
stat
Jun 8, 26
Major readouts from the annual diabetes conference
stat
Jun 8, 26
STAT+: Combination of pancreatic cancer drugs from Tango, Revolution leads to high response rate
stat
Jun 8, 26
Opinion: American horses are obese, too
stat
Jun 8, 26
Opinion: $2 million gene therapy cures require a financing model
stat
Jun 5, 26
STAT+: Up and down the ladder: The latest comings and goings
stat
Jun 5, 26
STAT+: Pharmalittle: We’re reading about Roche accusing U.S. of ‘blackmail,’ a ruling on skinny labels, and more
stat
Jun 4, 26
STAT+: Supreme Court backs generic drugmaker in ‘skinny labeling’ case
stat
Jun 4, 26
STAT+: For pancreatic cancer patients, an exciting drug can feel out of reach
stat
Jun 4, 26
STAT+: Pharmalittle: We’re reading about fewer pharma investments in Germany, growing U.S. layoffs, and more
stat
Jun 3, 26
STAT+: Legend Biotech emerged as a rare market winner
stat
Jun 3, 26
STAT+: Pharmalittle: We’re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more
stat
Jun 3, 26
Lilly, Ascidian link up in RNA exon editing pact
biopharma dive
Jun 2, 26
FDA details flexibilities for new cell and gene therapies to leverage past data
endpoints
← prev
page 5 of 8
next →
